Page last updated: 2024-08-23

lovastatin and Angina at Rest

lovastatin has been researched along with Angina at Rest in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boccuzzi, SJ; Cook, T; Gladstone, P; Higginson, L; Hudgin, R; Krip, G; Lespérance, J; Waters, D1
Carek, PJ; MacFarlane, LL1
Whitney, E1
Woodhouse, S1

Trials

1 trial(s) available for lovastatin and Angina at Rest

ArticleYear
Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group.
    Circulation, 1996, Aug-15, Volume: 94, Issue:4

    Topics: Adult; Angina, Unstable; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Lovastatin; Male; Middle Aged; Myocardial Infarction; Placebos; Smoking; Triglycerides

1996

Other Studies

3 other study(ies) available for lovastatin and Angina at Rest

ArticleYear
Lovastatin to prevent acute coronary events with average cholesterol levels.
    The Journal of family practice, 1998, Volume: 47, Issue:2

    Topics: Acute Disease; Aged; Angina, Unstable; Anticholesteremic Agents; Cholesterol; Coronary Disease; Death, Sudden, Cardiac; Double-Blind Method; Female; Humans; Lovastatin; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome

1998
The Air Force/Texas Coronary Atherosclerosis Prevention Study: implications for preventive cardiology in the general adult US population.
    Current atherosclerosis reports, 1999, Volume: 1, Issue:1

    Topics: Aged; Angina, Unstable; Cholesterol, LDL; Coronary Artery Disease; Death, Sudden, Cardiac; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lovastatin; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic

1999
C-reactive protein: from acute phase reactant to cardiovascular disease risk factor.
    MLO: medical laboratory observer, 2002, Volume: 34, Issue:3

    Topics: Acute-Phase Proteins; Angina, Unstable; Arteriosclerosis; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Education, Continuing; Humans; Lovastatin; Medical Laboratory Personnel; Risk Factors; United States

2002